COMMUNIQUÉS West-GlobeNewswire

Microbix Quality Products Enter U.S. Market
19/09/2019
Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, Ontario, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products [...]
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma
19/09/2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting [...]
ASLAN Pharmaceuticals Presents Late-Breaking Data From Phase 2 Study in China Testing Varlitinib in Second Line Biliary Tract Cancer at CSCO
19/09/2019
- Biliary tract cancer (BTC) patients treated with varlitinib plus capecitabine in second line achieved a response rate of 11% including two complete responses, median PFS of 2.7 months and OS of 5.8 months - Patients [...]
AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1
19/09/2019
New interim data from SPR1NT study supports critical importance of early intervention in pre-symptomatic SMA patients, leading to age‑appropriate major milestone gain Updated results from global STR1VE study demonstrate [...]
Inventiva completes a capital increase of € 8.2 million subscribed by leading US and European biotech investors
19/09/2019
New financing will enable the Company to extend from Q2 2020 to the end of Q3 2020 its cash runway beyond the ongoing lanifibranor and odiparcil clinical study results Capital raised at the closing price of 18 September [...]
Inventiva réalise une augmentation de capital de 8,2 millions d'euros souscrite par des investisseurs américains et européens de premier plan dans le secteur des biotechnologies
19/09/2019
Un nouveau financement permettant à la Société d'étendre sa visibilité financière du 2 ème trimestre 2020 jusqu'à la fin du 3 ème trimestre 2020 au-delà des résultats des études cliniques en cours sur lanifibranor et [...]
Annual Financial Report
19/09/2019
DXS INTERNATIONAL PLC ANNUAL RESULTS for the year ended 30 April 2019 The Board of DXS International plc (“the Company”), the NEX Growth Market quoted healthcare information and digital clinical decision support systems [...]
Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019
19/09/2019
LONDON, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces that it will present positive interim data [...]
Sequana Medical Appoints Leading Experts as Heart Failure Scientific Advisors
19/09/2019
Dr. Butler, Dr. Costanzo, Dr. Tang and Dr. Testani to advise on alfa pump® DSR development GHENT, Belgium, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA) , innovators in the management [...]
Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary
19/09/2019
Roche and Transnet, the main freight logistics company in South Africa, came together in 1994 to establish Phelophepa, the world’s first comprehensive primary healthcare facility on rail Phelophepa has touched the lives [...]
Roche renouvelle son engagement en faveur des trains médicaux Phelophepa, marquant leur 25e anniversaire
19/09/2019
Roche et Transnet, principale entreprise sud-africaine de logistique de fret, se sont associées en 1994 pour créer Phelophepa, premier établissement de soins de santé primaires complets sur rails au monde Depuis son [...]
PRA Health Sciences et Symphony Health lancent l'outil de mesure du marché national Metys(TM)
19/09/2019
Metys(TM) est le premier en son genre à fournir rapidement des données précises et fiables via un point d'accès unique RALEIGH, N.C., 19 sept. 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ : PRAH) a annoncé [...]
Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution
18/09/2019
Board Has Made Numerous Corporate Governance Enhancements Reflecting Feedback From Shareholders No Shareholder Action Required at this Time NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. ( [...]
Nxt-ID, Inc. names Vincent S. Miceli as new Chief Executive Officer
18/09/2019
SEBASTIAN, Florida, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company”), a provider of healthcare devices and services, announced today that Gino M. Pereira has resigned from his roles as [...]
Integra LifeSciences Presents Cadence® Total Ankle System Retrospective Study Abstract at AOFAS
18/09/2019
PLAINSBORO, N.J., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced positive findings from its Cadence® Total Ankle [...]
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 26, 2019
18/09/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]
Oasmia publishes report on special investigation of liability issues conducted by audit firm Deloitte
18/09/2019
In connection with Oasmia's year-end report in June 2019, the company's Board of Directors made a decision to engage a special examiner, audit firm Deloitte (Svante Forsberg responsible investigator), to investigate the [...]
Oasmia presents Q1 report through audiocast on September 26
18/09/2019
Oasmia will hold an audiocast and telephone conference on Thursday 26 September at 10:00 (CET) to present the company's Q1 report for the financial year 2019/2020. The presentation of the Q1 report will be in English. [...]
Dr. Emilio Canal, Jr., D.D.S., F.A.S.D. has been elected as President of the Professional Soccer Dental Society
18/09/2019
RESTON, Va., Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Dental Group at Reston Station is pleased to announce that Dr. Emilio Canal, Jr., D.D.S., F.A.S.D. has been elected as President of the Professional Soccer Dental [...]

Pages